Vanessa Ragaglia

Corporate Officer/Principal presso Garnet BioTherapeutics, Inc.

Consumer Services

Commercial Services

Profilo

Vanessa Ragaglia is currently working as the Lab Director at Celebration Stem Cell Centre and as the Vice President-Research at Garnet BioTherapeutics, Inc. She completed her undergraduate degree at Trinity College (Connecticut) and her doctorate degree at The Ohio State University College of Medicine.

Posizioni attive di Vanessa Ragaglia

Società	Posizione	Inizio
Garnet BioTherapeutics, Inc. Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA.	Corporate Officer/Principal	01/01/2000
Celebration Stem Cell Centre	Corporate Officer/Principal	-

Tutte le posizioni attive di Vanessa Ragaglia

Formazione di Vanessa Ragaglia

The Ohio State University College of Medicine	Doctorate Degree
Trinity College (Connecticut)	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Vanessa Ragaglia

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Garnet BioTherapeutics, Inc. Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA.	Commercial Services
Celebration Stem Cell Centre